Q/C Technologies, Inc. (QCLS) stock
QCLSNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.33+0.01 (+4.05%)
Close on Nov 17, 2026Market cap $2.74MP/E –Yield –
Q/C Technologies total assets
Total assets on the balance sheet at the end of each period.
Q/C Technologies's total assets was $22.87M at Jun 30, 2026. For fiscal 2025 it was $41.17M, up 92.2% from the year before. Over ten years it grew 17.4% a year on average. The highest annual figure on record is $41.17M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $41.17M | +92.2% |
| FY2024 | Dec 31, 2024 | $21.42M | +19.9% |
| FY2023 | Dec 31, 2023 | $17.86M | +1.8% |
| FY2022 | Dec 31, 2022 | $17.54M | -29.3% |
| FY2021 | Dec 31, 2021 | $24.81M | +3566.8% |
| FY2020 | Dec 31, 2020 | $676.70K | -93.8% |
| FY2019 | Dec 31, 2019 | $10.88M | +39.4% |
| FY2018 | Dec 31, 2018 | $7.81M | -16.4% |
| FY2017 | Dec 31, 2017 | $9.34M | +83.6% |
| FY2016 | Dec 31, 2016 | $5.09M | -38.5% |
| FY2015 | Dec 31, 2015 | $8.27M | -50.3% |
| FY2014 | Dec 31, 2014 | $16.65M | +174.1% |
| FY2013 | Dec 31, 2013 | $6.08M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $22.87M | +33.3% |
| Q1 FY2026 | Mar 31, 2026 | $38.29M | +103.9% |
| Q4 FY2025 | Dec 31, 2025 | $41.17M | +92.2% |
| Q3 FY2025 | Sep 30, 2025 | $37.23M | +54.9% |
| Q2 FY2025 | Jun 30, 2025 | $17.15M | +18.3% |
| Q1 FY2025 | Mar 31, 2025 | $18.78M | +5.1% |
| Q4 FY2024 | Dec 31, 2024 | $21.42M | -1.9% |
| Q3 FY2024 | Sep 30, 2024 | $24.04M | -4.8% |
| Q1 FY2024 | Mar 31, 2024 | $14.49M | -49.0% |
| Q4 FY2023 | Dec 31, 2023 | $17.86M | +1.8% |
| Q3 FY2023 | Sep 30, 2023 | $21.83M | +7.9% |
| Q2 FY2023 | Jun 30, 2023 | $25.25M | +31.8% |
| Q1 FY2023 | Mar 31, 2023 | $28.41M | +27.9% |
| Q4 FY2022 | Dec 31, 2022 | $17.54M | -29.3% |
| Q3 FY2022 | Sep 30, 2022 | $20.23M | -27.8% |
| Q2 FY2022 | Jun 30, 2022 | $19.16M | -44.4% |
| Q1 FY2022 | Mar 31, 2022 | $22.20M | -38.0% |
| Q4 FY2021 | Dec 31, 2021 | $24.81M | +3566.8% |
| Q3 FY2021 | Sep 30, 2021 | $28.01M | +18.1% |
| Q2 FY2021 | Jun 30, 2021 | $34.45M | +84.4% |
| Q1 FY2021 | Mar 31, 2021 | $35.80M | +292.4% |
| Q4 FY2020 | Dec 31, 2020 | $676.70K | -93.8% |
| Q3 FY2020 | Sep 30, 2020 | $23.72M | +377.2% |
| Q2 FY2020 | Jun 30, 2020 | $18.68M | +214.9% |
| Q1 FY2020 | Mar 31, 2020 | $9.12M | +29.5% |
| Q4 FY2019 | Dec 31, 2019 | $10.88M | +39.4% |
| Q3 FY2019 | Sep 30, 2019 | $4.97M | -50.4% |
| Q2 FY2019 | Jun 30, 2019 | $5.93M | -53.1% |
| Q1 FY2019 | Mar 31, 2019 | $7.04M | -45.0% |
| Q4 FY2018 | Dec 31, 2018 | $7.81M | -16.4% |
| Q3 FY2018 | Sep 30, 2018 | $10.02M | +54.2% |
| Q2 FY2018 | Jun 30, 2018 | $12.65M | +78.0% |
| Q1 FY2018 | Mar 31, 2018 | $12.80M | +151.7% |
| Q4 FY2017 | Dec 31, 2017 | $9.34M | +61.6% |
| Q2 FY2017 | Jun 30, 2017 | $6.50M | +14.4% |
| Q1 FY2017 | Mar 31, 2017 | $7.11M | +6.8% |
| Q4 FY2016 | Dec 31, 2016 | $5.09M | – |
| Q3 FY2016 | Sep 30, 2016 | $5.78M | – |
| Q2 FY2016 | Jun 30, 2016 | $5.68M | – |
| Q1 FY2016 | Mar 31, 2016 | $6.65M | – |
See a number that looks wrong?